Books > Medicine > Clinical & internal medicine > Diseases & disorders > Infectious & contagious diseases
|
Buy Now
The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa - Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa (Paperback)
Loot Price: R1,277
Discovery Miles 12 770
|
|
The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa - Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa (Paperback)
Expected to ship within 12 - 17 working days
|
Tuberculosis (TB) kills approximately 4,500 people worldwide every
day. While most cases of TB can be treated with antibiotics, some
strains have developed drug resistance that makes their treatment
more expensive, more toxic and less effective for the patient. The
IOM Forum on Drug Discovery, Development, and Translation and the
Academy of Science of South Africa held a workshop to discuss ways
to fight the growing threat of drug-resistant TB. Table of Contents
Front Matter 1 Introduction 2 The Incidence of Drug-Resistant TB in
Southern Africa 3 Surveillance and Tracking of Drug-Resistant TB 4
Transmission and Infection Control 5 Diagnosis of Drug-Resistant TB
6 Treatment of Drug-Resistant TB 7 Drug-Resistant TB in Children 8
Convergence of Science and Policy to Create a Blueprint for Action
References Appendix A: Agenda Appendix B: Report from the National
Institute of Allergy and Infectious Diseases (NIAID) Workshop
Appendix C: Participant Biographies
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.